Recent News

• 06.04.2025 - HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis
• 06.03.2025 - Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value
• 05.08.2025 - HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 – Featuring CEO Andrew Simpson
• 05.07.2025 - HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board
• 05.01.2025 - HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program
• 04.14.2025 - Transformation of Diagnostic Cardiology Using AI
• 04.14.2025 - CEO Andrew Simpson Discusses HeartSciences’ AI-ECG Solutions
• 03.13.2025 - HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results

Recent Filings

• 06.03.2025 - EX-99.1 EX-99.1
• 06.03.2025 - 8-K Current report
• 05.28.2025 - 8-K Current report
• 05.19.2025 - 8-K Current report
• 05.19.2025 - EX-99.1 EX-99.1
• 05.15.2025 - 253G2 253G2
• 03.21.2025 - 8-K Current report
• 03.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 03.13.2025 - EX-99.1 EX-99.1
• 03.13.2025 - 8-K Current report